120
Participants
Start Date
November 30, 2005
Study Completion Date
March 31, 2007
Exubera (inhaled insulin)
8-point glucose diary (to assess pre- and post prandial glucoses)
Meal Tolerance Test
24-hour continuous glucose monitoring (at select sites)
Pulmonary Function Testing
Hypoglycemic Event Monitoring
Laboratory Assessments
Nutritional Counseling and Diabetes Education
Pfizer Investigational Site, Birmingham
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, New Britain
Pfizer Investigational Site, Norwalk
Pfizer Investigational Site, Hollywood
Pfizer Investigational Site, Atlanta
Pfizer Investigational Site, Boise
Pfizer Investigational Site, Hayden
Pfizer Investigational Site, Baton Rouge
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Albany
Pfizer Investigational Site, Syracuse
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, El Paso
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Bennington